Aviva plc

Institutional investor · Portfolio as of Q2 2026

Top Holdings854 positions

Checking export access…
Activity:
NVDA

NVIDIA Corporation

22.1M$4.4B6.5%$69.92+141.56%
31 qtrssince 2018-Q4
Decreased
0
AAPL

Apple Inc.

13.3M$3.8B5.7%$145.17+140.07%
31 qtrssince 2018-Q4
Increased
62
MSFT

Microsoft Corporation

7.2M$2.7B4.0%$264.92+101.26%
31 qtrssince 2018-Q4
Increased
59
AMZN

Amazon.com, Inc.

8.6M$2.1B3.0%$147.22+83.99%
31 qtrssince 2018-Q4
Increased
61
GOOGL

Alphabet Inc.

5.7M$2.1B3.0%$112.33+155.84%
31 qtrssince 2018-Q4
Decreased
0
AZN

AstraZeneca PLC

10.9M$2B3.0%$197.22-5.30%
2 qtrssince 2026-Q1
Decreased
0
AVGO

Broadcom Inc.

4.7M$1.8B2.6%$117.99+181.36%
31 qtrssince 2018-Q4
Decreased
0
GOOG

Alphabet Inc.

4.5M$1.6B2.3%$119.37+138.69%
31 qtrssince 2018-Q4
Decreased
0
MU

Micron Technology, Inc.

1M$1.2B1.8%$134.01+441.10%
31 qtrssince 2018-Q4
Increased
52
META

Meta Platforms, Inc.

2M$1.1B1.7%$409.85+56.49%
31 qtrssince 2018-Q4
Increased
51
TSLA

Tesla, Inc.

2.5M$1.1B1.6%$210.47+80.45%
31 qtrssince 2018-Q4
Increased
51
JPM

JPMorgan Chase & Co.

3.1M$1B1.5%$196.95+73.68%
31 qtrssince 2018-Q4
Decreased
0
AMD

Advanced Micro Devices, Inc.

1.6M$915.8M1.3%$174.21+195.75%
31 qtrssince 2018-Q4
Increased
57
LLY

Eli Lilly and Company

718,261$861.5M1.3%$548.18+161.28%
31 qtrssince 2018-Q4
Increased
50
V

Visa Inc.

2.2M$747.1M1.1%$209.85+101.57%
31 qtrssince 2018-Q4
Increased
51
AMAT

Applied Materials, Inc.

850,706$615.1M0.9%$235.45+58.22%
31 qtrssince 2018-Q4
Increased
52
BRK/B

Berkshire Hathaway Inc.

1.2M$596.4M0.9%$392.72+48.54%
31 qtrssince 2018-Q4
Increased
46
JNJ

Johnson & Johnson

2.2M$549.3M0.8%$147.59+90.25%
31 qtrssince 2018-Q4
Increased
45
INTC

Intel Corporation

3.8M$537.1M0.8%$34.20+69.95%
31 qtrssince 2018-Q4
Increased
45
XOM

ExxonMobil Holdings Corporation

3.7M$509.6M0.8%$97.44+68.78%
31 qtrssince 2018-Q4
Increased
44
$67.9B
AUM
854
Positions
Q2 2026
Filing
HI rating · 3.0/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2025-Q1$41,446,379,3047.64987530446%
2025-Q2$48,423,872,31816.8349880766%
2025-Q3$55,023,318,67013.6284977555%
2025-Q4$59,300,748,7247.77384962847%
2026-Q1$59,606,790,9960.516085004971%
2026-Q2$67,921,992,51513.9500908874%
Activity profile
$ moved · Q2'26
New3%Increased70%Decreased25%Exited2%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 5.7 years
<1Q4%1-4Q6%1-2Y4%2Y+86%

Aviva plc manages $67.9B across 854 positions as of Q2 2026. Top holdings: NVDA (6.5%), AAPL (5.7%), MSFT (4.0%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.

Q2 2026 Summary

Active quarter - 72 new positions, 62 exits, 471 increased. Top move: AAPL (INCREASED, conviction 62). Portfolio: $67.9B across 854 positions.

Top holdings by portfolio weight

Total AUM$68B
NVDA6.52%
AAPL5.65%
MSFT3.95%
AMZN3.03%
GOOGL3.02%
AZN3.00%
AVGO2.61%
GOOG2.35%
MU1.76%
META1.68%
Other1.56%

Portfolio allocation by GICS sector

Sectors11
Technology35.61%
Financial Services12.45%
Healthcare11.39%
Communication Services9.21%
Consumer Cyclical9.09%
Industrials8.40%
Consumer Defensive4.40%
Energy3.57%
Basic Materials2.43%
Utilities1.85%
Other1.61%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Financial Services, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L61
Conviction50
Concentration50
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
ABBVABBVAbbVie Inc.
Q4 2024 → Q2 2026+729,061 shares+$234.1M
7Q
AEMAEMAgnico Eagle Mines Limited
Q4 2024 → Q2 2026+328,455 shares+$59.7M
7Q
ALNYALNYAlnylam Pharmaceuticals, Inc.
Q4 2024 → Q2 2026+90,026 shares+$27.7M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used